Genetic Testing Firms Tout Underlying Bioinformatics Capabilities as Key Business Component | GenomeWeb

By Uduak Grace Thomas

Last week, Gene Security Network, a prenatal genetic testing firm based in Redwood, Calif. launched a non-invasive prenatal paternity test.

Separately, Everist Genomics, a biotechnology company based in Ann, Arbor MI, launched a real-time PCR-based test dubbed OncoDefender-CRC that identifies early-stage colorectal cancer patients that may be at risk of the cancer recurring following treatment.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.